Abcellera Biologics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABCL and other ETFs, options, and stocks.About ABCL
AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease.
CEOCarl Lars G. Hansen
CEOCarl Lars G. Hansen
Employees596
Employees596
HeadquartersVancouver, British Columbia
HeadquartersVancouver, British Columbia
Founded2012
Founded2012
Employees596
Employees596
ABCL Key Statistics
Market cap1.29B
Market cap1.29B
Price-Earnings ratio-7.41
Price-Earnings ratio-7.41
Dividend yield—
Dividend yield—
Average volume5.40M
Average volume5.40M
High today$4.36
High today$4.36
Low today$4.12
Low today$4.12
Open price$4.25
Open price$4.25
Volume4.10M
Volume4.10M
52 Week high$6.52
52 Week high$6.52
52 Week low$1.89
52 Week low$1.89
Stock Snapshot
As of today, Abcellera Biologics(ABCL) shares are valued at $4.32. The company's market cap stands at 1.29B, with a P/E ratio of -7.41.
As of 2026-01-14, Abcellera Biologics(ABCL) stock has fluctuated between $4.12 and $4.36. The current price stands at $4.32, placing the stock +4.9% above today's low and -0.9% off the high.
The Abcellera Biologics(ABCL)'s current trading volume is 4.1M, compared to an average daily volume of 5.4M.
In the last year, Abcellera Biologics(ABCL) shares hit a 52-week high of $6.52 and a 52-week low of $1.89.
In the last year, Abcellera Biologics(ABCL) shares hit a 52-week high of $6.52 and a 52-week low of $1.89.
Analyst ratings
88%
of 8 ratingsBuy
87.5%
Hold
12.5%
Sell
0%
People also own
Based on the portfolios of people who own ABCL. This list is generated using Robinhood data, and it’s not a recommendation.